18 Oct 2017 09:00
Omega Diagnostics Group PLC
("Omega" or the "Company")
PDMR participation in SAYE scheme
Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that certain PDMRs of the Company have been granted sharesave option awards in the Company's save as you earn scheme ("SAYE Scheme") which gives them the opportunity to participate in the future growth of the Company via share award arrangements.
The SAYE Scheme grants participants the option to purchase ordinary shares of 4 pence each in the capital of the Company ("Ordinary Share") at a price of 18.4 pence per Ordinary Share and is exercisable between 1 November 2020 and 1 May 2021.
Accordingly, the Company makes the following announcement and notification in accordance with the EU Market Abuse Regulation (No 596/2014):
1) | Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA') | |||||
a) | Name | John Bannister | ||||
2. | Reason for notification | |||||
b) | Position / status | PDMR | ||||
c) | Initial notification / amendment | Initial Notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
b) | Name | Omega Diagnostics Group plc | ||||
c) | LEI | 2138007U9P4BTZTYIR92 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument Identification code
| Options over ordinary shares of 4p each
GB00B1VCP282 | ||||
b) | Nature of the transaction | Grant of share options under the Company's SAYE Scheme | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information Aggregated volume Price | n/a | ||||
e) | Date of the transaction | 18 October 2017 | ||||
f) | Place of the transaction | Outside a trading venue | ||||
1) | Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA') | |||||
a) | Name | Derek Brady | ||||
2. | Reason for notification | |||||
b) | Position / status | PDMR | ||||
c) | Initial notification / amendment | Initial Notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
b) | Name | Omega Diagnostics Group plc | ||||
c) | LEI | 2138007U9P4BTZTYIR92 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument Identification code
| Options over ordinary shares of 4p each
GB00B1VCP282 | ||||
b) | Nature of the transaction | Grant of share options under the Company's SAYE Scheme | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information Aggregated volume Price | n/a | ||||
e) | Date of the transaction | 18 October 2017 | ||||
f) | Place of the transaction | Outside a trading venue | ||||
1) | Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA') | |||||
a) | Name | Patrick Breen | ||||
2. | Reason for notification | |||||
b) | Position / status | PDMR | ||||
c) | Initial notification / amendment | Initial Notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
b) | Name | Omega Diagnostics Group plc | ||||
c) | LEI | 2138007U9P4BTZTYIR92 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument Identification code
| Options over ordinary shares of 4p each
GB00B1VCP282 | ||||
b) | Nature of the transaction | Grant of share options under the Company's SAYE Scheme | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information Aggregated volume Price | n/a | ||||
e) | Date of the transaction | 18 October 2017 | ||||
f) | Place of the transaction | Outside a trading venue | ||||
1) | Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA') | |||||
a) | Name | Michael Gordon | ||||
2. | Reason for notification | |||||
b) | Position / status | PDMR | ||||
c) | Initial notification / amendment | Initial Notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
b) | Name | Omega Diagnostics Group plc | ||||
c) | LEI | 2138007U9P4BTZTYIR92 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument Identification code
| Options over ordinary shares of 4p each
GB00B1VCP282 | ||||
b) | Nature of the transaction | Grant of share options under the Company's SAYE Scheme | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information Aggregated volume Price | n/a | ||||
e) | Date of the transaction | 18 October 2017 | ||||
f) | Place of the transaction | Outside a trading venue | ||||
1) | Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA') | |||||
a) | Name | Iain Logan | ||||
2. | Reason for notification | |||||
b) | Position / status | PDMR | ||||
c) | Initial notification / amendment | Initial Notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
b) | Name | Omega Diagnostics Group plc | ||||
c) | LEI | 2138007U9P4BTZTYIR92 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument Identification code
| Options over ordinary shares of 4p each
GB00B1VCP282 | ||||
b) | Nature of the transaction | Grant of share options under the Company's SAYE Scheme | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information Aggregated volume Price | n/a | ||||
e) | Date of the transaction | 18 October 2017 | ||||
f) | Place of the transaction | Outside a trading venue | ||||
1) | Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA') | |||||
a) | Name | Angela Robertson | ||||
2. | Reason for notification | |||||
b) | Position / status | PDMR | ||||
c) | Initial notification / amendment | Initial Notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
b) | Name | Omega Diagnostics Group plc | ||||
c) | LEI | 2138007U9P4BTZTYIR92 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument Identification code
| Options over ordinary shares of 4p each
GB00B1VCP282 | ||||
b) | Nature of the transaction | Grant of share options under the Company's SAYE Scheme | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information Aggregated volume Price | n/a | ||||
e) | Date of the transaction | 18 October 2017 | ||||
f) | Place of the transaction | Outside a trading venue | ||||
1) | Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA') | |||||
a) | Name | Edward Valente | ||||
2. | Reason for notification | |||||
b) | Position / status | PDMR | ||||
c) | Initial notification / amendment | Initial Notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
b) | Name | Omega Diagnostics Group plc | ||||
c) | LEI | 2138007U9P4BTZTYIR92 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument Identification code
| Options over ordinary shares of 4p each
GB00B1VCP282 | ||||
b) | Nature of the transaction | Grant of share options under the Company's SAYE Scheme | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information Aggregated volume Price | n/a | ||||
e) | Date of the transaction | 18 October 2017 | ||||
f) | Place of the transaction | Outside a trading venue | ||||
1) | Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA') | |||||
a) | Name | Jamie Yexley | ||||
2. | Reason for notification | |||||
b) | Position / status | PDMR | ||||
c) | Initial notification / amendment | Initial Notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
b) | Name | Omega Diagnostics Group plc | ||||
c) | LEI | 2138007U9P4BTZTYIR92 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument Identification code
| Options over ordinary shares of 4p each
GB00B1VCP282 | ||||
b) | Nature of the transaction | Grant of share options under the Company's SAYE Scheme | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information Aggregated volume Price | n/a | ||||
e) | Date of the transaction | 18 October 2017 | ||||
f) | Place of the transaction | Outside a trading venue | ||||
Contacts:
Omega Diagnostics Group PLC | Tel: 01259 763 030 |
Andrew Shepherd, Chief Executive | www.omegadiagnostics.com |
Kieron Harbinson, Group Finance Director | |
Jag Grewal, Group Sales and Marketing Director | |
finnCap Ltd | Tel: 020 7220 0500 |
Geoff Nash/James Thompson (Corporate Finance) | |
Mia Gardner (Corporate Broking) | |
Walbrook PR Limited | Tel: 020 7933 8780 or omega@walbrookpr.com |
Paul McManus | Mob: 07980 541 893 |
Lianne Cawthorne | Mob: 07584 391 303 |